Javascript must be enabled to continue!
CORRELATIONS OF ENDOGENOUS TESTOSTERONE AND DHEA-S IN PERIPHERAL ARTERIAL DISEASE
View through CrossRef
Background: Peripheral arterial disease is Occlusive disease of the arteries of the extremity. Common causes are
Atherosclerosis (most common), Buerger's disease, vasculitis and other arteritis, thromboembolism etc. Peripheral
arterial disease (PAD) is a treacherous disease as it remains asymptomatic for so long. As PAD progresses, it may lead to classical intermittent
claudication and critical limb ischemia. DHEAS has been demonstrated to have an antiatherosclerotic effect by prevention of platelet
aggregation, uptake of cholesterol and a decrease in the proliferation of vascular smooth muscle cells. Testosterone causes vasodilation of the
peripheral arteries by acting on the endothelium of the vessels and in turn results in release of nitric oxide (NO) which is a vasodilator and helps in
vasodilation. Testosterone suppresses expression of vascular cell adhesion molecule-1 (proinammatory cytokines), anti-inammatory factors
by its derivative 5-dihydrotestosterone which is the earliest step in atherosclerosis. Interestingly Testosterone and DHEAS also has benecial
effects on cardiac ischemia, angina and chronic heart failure. The aim of this study is to look for any relationship of Testosterone and DHEAS in
Peripheral Arterial Disease. Total 50 patients both inpatients and out Methods: patients were studied. The period of study was from September
2016 to June 2018. Patients who were proven to have peripheral arterial disease on colour doppler were taken for study. The study was done to
look if any relationship is present between serum testosterone and dehydroepiandrosterone sulfate (DHEA-S) in a peripheral arterial disease
patients. Data were documented and stored in a proper database format. At the end of data collection from the samples, data analysis was done
using SPSS 16 software and appropriate tests of signicance were applied. For categorical variables Chi-square test and Fischer's Exact test was
used. For comparing two groups of mean student's t-test was used. To correlate more than two continuous data Pearson and Spearman
Correlation Coefcient was used. P value <0.05 considered as statistically signicant. Our results showed that total serum testosterone Results:
and DHEA-S were not signicantly decreased in PAD patients in comparison to the control group. We could not observe any signicant
correlation. These results express that there is no signicant correlation Conclusion: of Serum Testosterone and Dehydroepiandosterone with
Peripheral arterial Disease. In our study there are signicant correlations with inammatory markers (C reactive protein, Interleukin6,
Homocysteine) Lipid prole (cholesterol, Triglyceride, HDL, VLDL) and HbA1C with serum Testosterone and Dehydroepiandosterone in
Peripheral Arterial Disease
Title: CORRELATIONS OF ENDOGENOUS TESTOSTERONE AND DHEA-S IN PERIPHERAL ARTERIAL DISEASE
Description:
Background: Peripheral arterial disease is Occlusive disease of the arteries of the extremity.
Common causes are
Atherosclerosis (most common), Buerger's disease, vasculitis and other arteritis, thromboembolism etc.
Peripheral
arterial disease (PAD) is a treacherous disease as it remains asymptomatic for so long.
As PAD progresses, it may lead to classical intermittent
claudication and critical limb ischemia.
DHEAS has been demonstrated to have an antiatherosclerotic effect by prevention of platelet
aggregation, uptake of cholesterol and a decrease in the proliferation of vascular smooth muscle cells.
Testosterone causes vasodilation of the
peripheral arteries by acting on the endothelium of the vessels and in turn results in release of nitric oxide (NO) which is a vasodilator and helps in
vasodilation.
Testosterone suppresses expression of vascular cell adhesion molecule-1 (proinammatory cytokines), anti-inammatory factors
by its derivative 5-dihydrotestosterone which is the earliest step in atherosclerosis.
Interestingly Testosterone and DHEAS also has benecial
effects on cardiac ischemia, angina and chronic heart failure.
The aim of this study is to look for any relationship of Testosterone and DHEAS in
Peripheral Arterial Disease.
Total 50 patients both inpatients and out Methods: patients were studied.
The period of study was from September
2016 to June 2018.
Patients who were proven to have peripheral arterial disease on colour doppler were taken for study.
The study was done to
look if any relationship is present between serum testosterone and dehydroepiandrosterone sulfate (DHEA-S) in a peripheral arterial disease
patients.
Data were documented and stored in a proper database format.
At the end of data collection from the samples, data analysis was done
using SPSS 16 software and appropriate tests of signicance were applied.
For categorical variables Chi-square test and Fischer's Exact test was
used.
For comparing two groups of mean student's t-test was used.
To correlate more than two continuous data Pearson and Spearman
Correlation Coefcient was used.
P value <0.
05 considered as statistically signicant.
Our results showed that total serum testosterone Results:
and DHEA-S were not signicantly decreased in PAD patients in comparison to the control group.
We could not observe any signicant
correlation.
These results express that there is no signicant correlation Conclusion: of Serum Testosterone and Dehydroepiandosterone with
Peripheral arterial Disease.
In our study there are signicant correlations with inammatory markers (C reactive protein, Interleukin6,
Homocysteine) Lipid prole (cholesterol, Triglyceride, HDL, VLDL) and HbA1C with serum Testosterone and Dehydroepiandosterone in
Peripheral Arterial Disease.
Related Results
In rats, oral oleoyl-DHEA is rapidly hydrolysed and converted to DHEA-sulphate
In rats, oral oleoyl-DHEA is rapidly hydrolysed and converted to DHEA-sulphate
Abstract
Background
Dehydroepiandrosterone (DHEA) released by adrenal glands may be converted to androgens and estrogens mainly in the gonadal, a...
Analog-Based Free Testosterone Test Results Linked to Total Testosterone Concentrations, Not Free Testosterone Concentrations
Analog-Based Free Testosterone Test Results Linked to Total Testosterone Concentrations, Not Free Testosterone Concentrations
Abstract
Background: Analog-based free testosterone test results, sex hormone binding globulin (SHBG) concentrations, and total testosterone concentrations are someh...
Abstract B61: Effects of anti-obesity dietary supplement DHEA on serum DHEA, DHEA-S, IGF-1 and IGFBP-3 in DMBA-induced breast cancer model.
Abstract B61: Effects of anti-obesity dietary supplement DHEA on serum DHEA, DHEA-S, IGF-1 and IGFBP-3 in DMBA-induced breast cancer model.
Abstract
Obesity has been epidemic in the US for over two decades. Obesity has been linked to the risk of development of various cancers, including breast cancer. De...
Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating Estrogens
Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating Estrogens
The most abundant human steroids, dehydroepiandrosterone (DHEA) and its sulfate ester DHEAS, may have a multitude of beneficial effects, but decline with age. DHEA possibly prevent...
Effect of Pretreatment with Coenzyme Q10 and DHEA before ART in Patients with Diminished Ovarian Reserve
Effect of Pretreatment with Coenzyme Q10 and DHEA before ART in Patients with Diminished Ovarian Reserve
Objective (s): Aim of this study was to explore the efficacy of pretreatment with a combination of coenzyme Q10 (CoQ10) and dehydroepiandrosterone (DHEA) in comparison to that of D...
In vivo activation of the constitutive androstane receptor β (CARβ) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEA‐S)
In vivo activation of the constitutive androstane receptor β (CARβ) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEA‐S)
We investigated whether dehydroepiandrosterone (DHEA) or DHEA‐sulfate (S) affected the activities of nuclear receptors, with special reference to constitutive androstane receptor β...
An LC/MS method for the quantitative determination of 7α‐OH DHEA and 7β‐OH DHEA: an application for the study of the metabolism of DHEA in rat brain
An LC/MS method for the quantitative determination of 7α‐OH DHEA and 7β‐OH DHEA: an application for the study of the metabolism of DHEA in rat brain
AbstractDehydroepiandrosterone (DHEA) is an important neurosteroid with neuronal protection and memory enhancement functions. 7α‐OH DHEA and 7β‐OH DHEA are the two important metabo...
Dehydroepiandrosterone (DHEA) Serum Levels Sufficiently Predict Cerebrospinal Fluid Levels of DHEA and Estradiol (E2) in Women at Term Pregnancy
Dehydroepiandrosterone (DHEA) Serum Levels Sufficiently Predict Cerebrospinal Fluid Levels of DHEA and Estradiol (E2) in Women at Term Pregnancy
Abstract
Background and objectives:Neuroactive steroids such as dehydroepiandrosterone (DHEA), estradiol (E2), and progesterone (P4) are associated with structural and func...

